Last updated: 2026-10-14 11:49:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
DaVita Inc. (DVA) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NYSE. The stock is currently priced at $185.93, with a market capitalization of $11.60B and a P/E ratio of 13.71. Over the past 52 weeks, its price has ranged from $101.00 to $247.49. This page covers its latest market performance, valuation, price trends and company information.
$11.60B | |
$180.64 | |
$247.49 | |
$10.22 | |
$182.08 | |
5.00 | |
758.88K | |
13.71 | |
$247.49 | |
$101.00 | |
-- | |
-- |
DaVita Inc. (DVA) is trading at $185.93 in pre-market trading as of 2026-10-14 10:50:00, up 2.11% ($3.85) from the previous close of $182.08
Pre-market trading shows how investors are pricing DVA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, DaVita Inc. (DVA) moved from $178.72 to $185.93, representing a gain of 4.03% ($7.21).
The stock traded between $175.41 and $185.93 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 487.97 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 58.0%
DVA is currently trading at $185.93, placing it 58.0% of the way from its 52-week low of $101.00 to its 52-week high of $247.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 78000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of DaVita Inc. (DVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.